home / stock / amrn / amrn news

AMRN News and Press, Amarin Corporation plc From 08/07/23

Stock Information
Company Name: Amarin Corporation plc
Stock Symbol: AMRN
Market: NASDAQ
Website: amarincorp.com
Menu
AMRN AMRN Quote AMRN Short AMRN News AMRN Articles AMRN Message Board
Get AMRN Alerts

News, Short Squeeze, Breakout and More Instantly...
AMRN - Scottish Medicines Consortium Accepts VAZKEPA® (icosapent ethyl) to Help Reduce Cardiovascular Risk for Patients in Scotland(1)

-- VAZKEPA® (icosapent ethyl) accepted by the Scottish Medicines Consortium (SMC) for restricted use within NHSScotland, as secondary prevention in adult statin-treated patients at high cardiovascular risk 1 -- -- VAZKEPA® already commercially available in Engl...
AMRN - Amarin Non-GAAP EPS of $0.02 beats by $0.05, revenue of $80.17M beats by $5.65M

2023-08-02 07:40:19 ET Amarin press release ( NASDAQ: AMRN ): Q2 Non-GAAP EPS of $0.02 beats by $0.05 . Revenue of $80.17M (-15.1% Y/Y) beats by $5.65M . Total Net Revenues Included Net Product Revenues of $65 Million, $15 Million in License and Royalty Revenue...

AMRN - Amarin Reports Second Quarter 2023 Financial Results

-- Company Reported Total Net Revenues of $80 Million in Second Quarter 2023; Total Net Revenues Included Net Product Revenues of $65 Million, $15 Million in License and Royalty Revenues, of Which $11 Million is Non-Cash -- -- Delivered Positive Cash Flow of $9 Million in the Quarter wi...

AMRN - Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea

DUBLIN, Ireland and BRIDGEWATER, N.J. and NANTOU, Taiwan, July 31, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) and Lotus Pharmaceuticals (1795:TT; “Lotus”) today announced that the two companies have entered into a long-term exclusive partnership to distribute and ...
AMRN - Latest Research Evaluating Clinical Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the European Society of Cardiology (ESC) Congress

DUBLIN, Ireland and BRIDGEWATER, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced the acceptance of funded research for presentation at the European Society of Cardiology (ESC) Congress, both onsite and online in Amsterdam, August 25-28, 2023. This new ...

AMRN - Amarin Receives Positive Recommendation from Spanish Drug Pricing Committee for National Reimbursement of VAZKEPA® (icosapent ethyl) in Spain

-- Spain’s Drug Pricing Committee recommends reimbursement of VAZKEPA ® (icosapent ethyl) to reduce the risk of cardiovascular (CV) events in patients with high cardiovascular risk 1 -- -- Positive recommendation marks the final step in the reimbursement proc...

AMRN - Amarin Board of Directors Announces Executive Compensation Program for New President and CEO Patrick Holt

– Agreement Underscores Board’s Commitment to Aligning Executive Compensation with Shareholder Returns – DUBLIN, Ireland and BRIDGEWATER, N.J., July 20, 2023 (GLOBE NEWSWIRE) -- Today the Board of Directors of Amarin Corporation plc (NASDAQ: AMRN) announced details ...
AMRN - Panbela, 60 Degrees top healthcare gainers; Amarin, Aptevo among losers

2023-07-19 10:22:17 ET Gainers: Panbela Therapeutics ( PBLA ) +36% . 60 Degrees Pharmaceuticals ( SXTP ) +20% . CareMax ( CMAX ) +20% . Biodexa Pharmaceuticals ( BDRX ) +13% . bluebird bio ( BLUE ) +13% . Losers: Amar...

AMRN - TOST, GP and GNPX among pre-market losers

2023-07-19 08:30:52 ET Aqua Metals ( AQMS ) -27% after disclosing stock offering . Amarin Corporation ( AMRN ) -20% on plan to undergo restructuring . Biophytis ( BPTS ) -18% on $3.8M offering . Genprex ( GNPX ) -14% on $7.5 Millio...

AMRN - Amarin appoints CEO

2023-07-18 16:24:34 ET Pharmaceutical company Amarin Corporation ( NASDAQ: AMRN ) said on Tuesday that that its board has appointed Patrick Holt president, CEO and board member, effective immediately. Interim President and CEO Aaron Berg will remain with the company ...
Previous 10 Next 10